REVB Revelation Biosciences, Inc.
Healthcare$1.07-0.93%ClosedMarket Cap: $4.2M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.26
P/S
0.00
EV/EBITDA
0.91
DCF Value
$15.15
FCF Yield
-209.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-107.7%
ROA
-65.6%
ROIC
-73.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-3.1M | $-3.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.6M | $-2.5M | $— | — |
| FY null | $0.00 | NaN% | $-9.1M | $-8.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.9M | $-1.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.5M | $-2.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.1M | $-2.1M | $— | — |
| Q4 null | $27.0K | 50.0% | $-1.8M | $-1.7M | $— | — |
| FY null | $0.00 | -Infinity% | $-8.0M | $-15.0M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.8M | $-2.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.5M | $-8.4M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-1.9M | $-2.7M | $— | — |
| Q4 2023 | $37.6K | 50.0% | $-2.3M | $-2.2M | $-133.24 | — |